Sanara MedTech reported Q EPS of $0.04, missing the Zacks consensus of $0.11 by $0.07 (about 64% below consensus). The result, however, represents a swing from a loss of $0.18 a year ago (improvement of $0.22 per share). Expect this mixed outcome to primarily affect the individual stock rather than the sector.
Sanara MedTech reported Q EPS of $0.04, missing the Zacks consensus of $0.11 by $0.07 (about 64% below consensus). The result, however, represents a swing from a loss of $0.18 a year ago (improvement of $0.22 per share). Expect this mixed outcome to primarily affect the individual stock rather than the sector.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
